Cuprina Holdings (Cayman) Limited Class A Ordinary Shares CUPR
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares SYBX
Synlogic, Inc. LSTA
Lisata Therapeutics, Inc. LIXT
Lixte Biotechnology Holdings, Inc. HOTH
Hoth Therapeutics, Inc. APLM
Apollomics, Inc. CLSD
Clearside Biomedical, Inc. LNAI
Lunai Bioworks Inc. BCTX
BriaCell Therapeutics Corp. PCSA
Processa Pharmaceuticals, Inc.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares SYBX
Synlogic, Inc. LSTA
Lisata Therapeutics, Inc. LIXT
Lixte Biotechnology Holdings, Inc. HOTH
Hoth Therapeutics, Inc. APLM
Apollomics, Inc. CLSD
Clearside Biomedical, Inc. LNAI
Lunai Bioworks Inc. BCTX
BriaCell Therapeutics Corp. PCSA
Processa Pharmaceuticals, Inc.
Performance
| Periode | CUPR | SYBX | LSTA | LIXT | HOTH | APLM | CLSD | LNAI | BCTX | PCSA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -80.48 % | 72.64 % | 7.02 % | 262.90 % | 81.46 % | 520.14 % | -68.42 % | -47.37 % | -71.72 % | 39.09 % |
| YTD | -77.19 % | 28.87 % | -31.65 % | 102.70 % | 81.79 % | 239.35 % | -73.55 % | -47.37 % | -86.38 % | -66.01 % |
| 1Y | -77.19 % | 27.08 % | -18.12 % | 134.38 % | 59.09 % | 167.91 % | -80.86 % | -47.37 % | -90.08 % | -78.30 % |
| 3Y | -77.19 % | -88.59 % | -41.35 % | -19.64 % | -83.29 % | -96.39 % | -77.03 % | -47.37 % | -98.73 % | -99.24 % |
| 5Y | -77.19 % | -93.99 % | -90.32 % | -93.53 % | -96.92 % | -96.30 % | -82.45 % | -47.37 % | -71.65 % | -99.65 % |
| 10Y | -77.19 % | -95.51 % | -98.76 % | -53.13 % | -99.34 % | -96.30 % | -96.51 % | -47.37 % | 11 504 854 368 832.04 % | -99.64 % |
| From the beginning | -77.19 % | -44.04 % | -100.00 % | -99.83 % | -99.34 % | -96.30 % | -96.51 % | -47.37 % | 1 814 701 378 154.21 % | -99.91 % |